XM2Q51ICD-11 MMS 2026-01
Antithymocyte immunoglobulin (rabbit)
Index terms
- Antithymocyte immunoglobulin (rabbit)
Sibling codes
XM0700– OzanimodXM09N4– ImlifidaseXM0V48– UpadacitinibXM1835– TeriflunomideXM1PC0– AnifrolumabXM1PY3– AlefaceptXM1SM6– BaricitinibXM2B74– OcrelizumabXM31G3– RavulizumabXM3F23– EmapalumabXM3KK5– EculizumabXM3RJ6– PeficitinibXM3TG8– Antilymphocyte immunoglobulin (horse)XM45M8– AbataceptXM4FP8– BelataceptXM4RN7– AbetimusXM57B1– Mycophenolic acidXM5M04– LeflunomideXM5MC2– VedolizumabXM69Y4– PonesimodXM6N55– SiponimodXM6PD2– SutimlimabXM6QJ6– BelumosudilXM75G0– GusperimusXM76R4– SirolimusXM7BS8– BegelomabXM7U27– TofacitinibXM8913– PegcetacoplanXM8AR9– TeprotumumabXM8CX4– EfalizumabXM93Q8– DeucravacitinibXM9K56– FingolimodXM9M75– BelimumabXM9RY3– Muromonab-CD3XM9UD1– ApremilastXM9YN4– Natalizumab
Foundation entity
Antithymocyte immunoglobulin (rabbit) – http://id.who.int/icd/entity/1785010931
Part of: XM5140: Selective immunosuppressants › XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes